Skip to content

Endonasal Dacryocystorhinostomy and Evolution of the Stoma Size

Endonasal Dacryocystorhinostomy: Prospective Study of the Evolution of the Stoma Size

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04054791
Acronym
EndoDCRevol
Enrollment
18
Registered
2019-08-13
Start date
2016-01-01
Completion date
2019-07-01
Last updated
2019-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endonasal Dacryocystorhinostomy

Brief summary

Dacryocystorhinostomy (DCR) is a procedure of choice for nasolacrimal duct obstruction. Endonasal procedures for DCR were described as early as 1893 by Caldwell. However, external DCR was practiced more commonly because of better visualization of anatomic features. The miniaturization of surgical instruments and close partnership between ophthalmologist and otorhinolaryngologist had led to a renewal of endonasal approach. The main objective of the study is to show the evolution of stoma size after endonasal DCR and validate the direct measurement of mucous orifice. It will also allow determining if the stoma evolution size may be a predictive factor for operational effectiveness.

Interventions

None listed

Sponsors

Centre Hospitalier Régional Metz-Thionville
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with chronic epiphora or chronic dacryocystitis

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Evolution of the stoma sizeMonth 12Measurement of the stoma size by endonasal photography

Secondary

MeasureTime frameDescription
Mucous orifices sizeMonth 2Measurement of the osteotomy orifices size from photography
Ratio of patients for whom the operation is a successMonth 12A success corresponds to the complete disappearance of epiphora symptomatology, on the contrary, a failure equals to the persistence of tearing or a recurrence of dacryocystitis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026